{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T04:35:06Z","timestamp":1785386106033,"version":"3.55.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T00:00:00Z","timestamp":1684886400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T00:00:00Z","timestamp":1684886400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"abstract":"<jats:title>Abstract<\/jats:title><jats:sec>\n                <jats:title>Purpose<\/jats:title>\n                <jats:p>Transsphenoidal surgery for non-functioning pituitary adenomas (NFPAs) can alter pituitary function. We assessed the rates of improvement and deterioration of pituitary function by axis and searched for predictive factors of these outcomes.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Methods<\/jats:title>\n                <jats:p>We reviewed consecutive medical files from patients having had transsphenoidal surgery for NFPA between 2004 and 2018. Pituitary functions and MRI imaging were analyzed prior and after surgery. The occurrence of recovery and new deficit were documented per axis. Prognostic factors of hormonal recovery and new deficits were searched.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Results<\/jats:title>\n                <jats:p>Among 137 patients analyzed, median tumor size of the NFPA was 24.8\u2009mm and 58.4% of patients presented visual impairment. Before surgery, 91 patients (67%) had at least one abnormal pituitary axis (hypogonadism: 62.4%; hypothyroidism: 41%, adrenal insufficiency: 30.8%, growth hormone deficiency: 29.9%; increased prolactin: 50.8%). Following surgery, the recovery rate of pituitary deficiency of one axis or more was 46% and the rate of new pituitary deficiency was 10%. Rates of LH-FSH, TSH, ACTH and GH deficiency recovery were 35.7%, 30.4%, 15.4%, and 45.5% respectively. Rates of new LH-FSH, TSH, ACTH and GH deficiencies were 8.3%, 1.6%, 9.2% and 5.1% respectively. Altogether, 24.6% of patients had a global pituitary function improvement and only 7% had pituitary function worsening after surgery. Male patients and patients with hyperprolactinemia upon diagnosis were more likely to experience pituitary function recovery. No prognostic factors for the risk of new deficiencies were identified.<\/jats:p>\n              <\/jats:sec><jats:sec>\n                <jats:title>Conclusion<\/jats:title>\n                <jats:p>In a real-life cohort of patients with NFPAs, recovery of hypopituitarism after surgery is more frequent than the occurrence of new deficiencies. Hence, hypopituitarism could be considered a relative indication for surgery in patients with NFPAs.<\/jats:p>\n              <\/jats:sec>","DOI":"10.1007\/s12020-023-03400-z","type":"journal-article","created":{"date-parts":[[2023,5,24]],"date-time":"2023-05-24T10:02:41Z","timestamp":1684922561000},"page":"340-348","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":27,"title":["The impact of transsphenoidal surgery on pituitary function in patients with non-functioning macroadenomas"],"prefix":"10.1007","volume":"81","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3085-2928","authenticated-orcid":false,"given":"Maria","family":"Mavromati","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Mavrakanas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois R.","family":"Jornayvaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karl","family":"Schaller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aikaterini","family":"Fitsiori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria I.","family":"Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes A.","family":"Lobrinus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doron","family":"Merkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristof","family":"Egervari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Philippe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Leboulleux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahan","family":"Momjian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,24]]},"reference":[{"issue":"12","key":"3400_CR1","doi-asserted-by":"publisher","first-page":"4769","DOI":"10.1210\/jc.2006-1668","volume":"91","author":"AF Daly","year":"2006","unstructured":"A.F. Daly et al. High prevalence of pituitary adenomas: a cross-sectional study in the province of Liege, Belgium. J. Clin. Endocrinol. Metab. 91(12), 4769\u20134775 (2006)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"3400_CR2","doi-asserted-by":"publisher","first-page":"377","DOI":"10.1111\/j.1365-2265.2009.03667.x","volume":"72","author":"A Fernandez","year":"2010","unstructured":"A. Fernandez, N. Karavitaki, J.A. Wass, Prevalence of pituitary adenomas: a community-based, cross-sectional study in Banbury (Oxfordshire, UK). Clin. Endocrinol. 72(3), 377\u2013382 (2010)","journal-title":"Clin. Endocrinol."},{"issue":"3","key":"3400_CR3","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1016\/j.ando.2015.04.002","volume":"76","author":"P Chanson","year":"2015","unstructured":"P. Chanson et al. Management of clinically non-functioning pituitary adenoma. Ann. Endocrinol. 76(3), 239\u2013247 (2015)","journal-title":"Ann. Endocrinol."},{"issue":"5","key":"3400_CR4","doi-asserted-by":"publisher","first-page":"753","DOI":"10.1530\/eje.1.02107","volume":"154","author":"H Buurman","year":"2006","unstructured":"H. Buurman, W. Saeger, Subclinical adenomas in postmortem pituitaries: classification and correlations to clinical data. Eur. J. Endocrinol. 154(5), 753\u2013758 (2006)","journal-title":"Eur. J. Endocrinol."},{"issue":"4","key":"3400_CR5","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1590\/2359-3997000000179","volume":"60","author":"LN Vieira","year":"2016","unstructured":"L.N. Vieira et al. A review on the diagnosis and treatment of patients with clinically nonfunctioning pituitary adenoma by the Neuroendocrinology Department of the Brazilian Society of Endocrinology and Metabolism. Arch. Endocrinol. Metab. 60(4), 374\u2013390 (2016)","journal-title":"Arch. Endocrinol. Metab."},{"issue":"4","key":"3400_CR6","doi-asserted-by":"publisher","first-page":"894","DOI":"10.1210\/jc.2010-1048","volume":"96","author":"PU Freda","year":"2011","unstructured":"P.U. Freda et al. Pituitary incidentaloma: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 96(4), 894\u2013904 (2011)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"3400_CR7","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1530\/eje.1.02326","volume":"156","author":"W Saeger","year":"2007","unstructured":"W. Saeger et al. Pathohistological classification of pituitary tumors: 10 years of experience with the German Pituitary Tumor Registry. Eur. J. Endocrinol. 156(2), 203\u2013216 (2007)","journal-title":"Eur. J. Endocrinol."},{"issue":"3","key":"3400_CR8","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.ecl.2020.04.002","volume":"49","author":"AF Daly","year":"2020","unstructured":"A.F. Daly, A. Beckers, The epidemiology of pituitary adenomas. Endocrinol. Metab. Clin. North Am. 49(3), 347\u2013355 (2020)","journal-title":"Endocrinol. Metab. Clin. North Am."},{"issue":"1","key":"3400_CR9","doi-asserted-by":"publisher","first-page":"6","DOI":"10.1007\/s12022-022-09703-7","volume":"33","author":"SL Asa","year":"2022","unstructured":"S.L. Asa et al. Overview of the 2022 WHO Classification of Pituitary Tumors. Endocr. Pathol. 33(1), 6\u201326 (2022)","journal-title":"Endocr. Pathol."},{"issue":"10","key":"3400_CR10","doi-asserted-by":"publisher","first-page":"3717","DOI":"10.1210\/jc.2008-0643","volume":"93","author":"OM Dekkers","year":"2008","unstructured":"O.M. Dekkers, A.M. Pereira, J.A. Romijn, Treatment and follow-up of clinically nonfunctioning pituitary macroadenomas. J. Clin. Endocrinol. Metab. 93(10), 3717\u20133726 (2008)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"3","key":"3400_CR11","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1016\/j.ando.2015.04.007","volume":"76","author":"F Castinetti","year":"2015","unstructured":"F. Castinetti et al. Non-functioning pituitary adenoma: when and how to operate? What pathologic criteria for typing?. Ann. Endocrinol. 76(3), 220\u2013227 (2015)","journal-title":"Ann. Endocrinol."},{"issue":"6","key":"3400_CR12","doi-asserted-by":"publisher","first-page":"777","DOI":"10.1111\/j.1365-2265.2010.03875.x","volume":"73","author":"MH Murad","year":"2010","unstructured":"M.H. Murad et al. Outcomes of surgical treatment for nonfunctioning pituitary adenomas: a systematic review and meta-analysis. Clin. Endocrinol. 73(6), 777\u2013791 (2010)","journal-title":"Clin. Endocrinol."},{"issue":"11","key":"3400_CR13","doi-asserted-by":"publisher","first-page":"3888","DOI":"10.1210\/jc.2016-2118","volume":"101","author":"M Fleseriu","year":"2016","unstructured":"M. Fleseriu et al. Hormonal replacement in hypopituitarism in adults: an endocrine society clinical practice guideline. J. Clin. Endocrinol. Metab. 101(11), 3888\u20133921 (2016)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"3400_CR14","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1007\/s11102-018-0863-9","volume":"21","author":"M Tampourlou","year":"2018","unstructured":"M. Tampourlou et al. Mortality in patients with non-functioning pituitary adenoma. Pituitary 21(2), 203\u2013207 (2018)","journal-title":"Pituitary"},{"issue":"1","key":"3400_CR15","doi-asserted-by":"publisher","first-page":"67","DOI":"10.1007\/s11102-007-0018-x","volume":"10","author":"EH Nielsen","year":"2007","unstructured":"E.H. Nielsen et al. Nonfunctioning pituitary adenoma: incidence, causes of death and quality of life in relation to pituitary function. Pituitary 10(1), 67\u201373 (2007)","journal-title":"Pituitary"},{"issue":"7","key":"3400_CR16","doi-asserted-by":"publisher","first-page":"2651","DOI":"10.1210\/jc.2015-1475","volume":"100","author":"DS Olsson","year":"2015","unstructured":"D.S. Olsson et al. Excess mortality in women and young adults with nonfunctioning pituitary adenoma: a Swedish Nationwide Study. J. Clin. Endocrinol. Metab. 100(7), 2651\u20132658 (2015)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"2","key":"3400_CR17","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1530\/EJE-15-0967","volume":"174","author":"G Ntali","year":"2016","unstructured":"G. Ntali et al. Mortality in patients with non-functioning pituitary adenoma is increased: systematic analysis of 546 cases with long follow-up. Eur. J. Endocrinol. 174(2), 137\u2013145 (2016)","journal-title":"Eur. J. Endocrinol."},{"issue":"10","key":"3400_CR18","doi-asserted-by":"publisher","first-page":"E1938","DOI":"10.1210\/jc.2012-2432","volume":"97","author":"T Zueger","year":"2012","unstructured":"T. Zueger et al. Glucocorticoid replacement and mortality in patients with nonfunctioning pituitary adenoma. J. Clin. Endocrinol. Metab. 97(10), E1938\u2013E1942 (2012)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"4","key":"3400_CR19","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1530\/EJE-18-0370","volume":"179","author":"C Hammarstrand","year":"2018","unstructured":"C. Hammarstrand et al. Comorbidities in patients with non-functioning pituitary adenoma: influence of long-term growth hormone replacement. Eur. J. Endocrinol. 179(4), 229\u2013237 (2018)","journal-title":"Eur. J. Endocrinol."},{"issue":"5","key":"3400_CR20","doi-asserted-by":"publisher","first-page":"748","DOI":"10.1111\/cen.13141","volume":"85","author":"MW O\u2019Reilly","year":"2016","unstructured":"M.W. O\u2019Reilly et al. ACTH and gonadotropin deficiencies predict mortality in patients treated for nonfunctioning pituitary adenoma: long-term follow-up of 519 patients in two large European centres. Clin. Endocrinol. 85(5), 748\u2013756 (2016)","journal-title":"Clin. Endocrinol."},{"issue":"2","key":"3400_CR21","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1007\/s11102-010-0280-1","volume":"14","author":"JA Gondim","year":"2011","unstructured":"J.A. Gondim et al. Endoscopic endonasal approach for pituitary adenoma: surgical complications in 301 patients. Pituitary 14(2), 174\u2013183 (2011)","journal-title":"Pituitary"},{"key":"3400_CR22","doi-asserted-by":"publisher","first-page":"e409","DOI":"10.1016\/j.wneu.2017.09.194","volume":"109","author":"JH Kim","year":"2018","unstructured":"J.H. Kim et al. Endoscopic transsphenoidal surgery outcomes in 331 nonfunctioning pituitary adenoma cases after a single surgeon learning curve. World Neurosurg. 109, e409\u2013e416 (2018)","journal-title":"World Neurosurg."},{"issue":"4","key":"3400_CR23","doi-asserted-by":"publisher","first-page":"E11","DOI":"10.3171\/2011.1.FOCUS10308","volume":"30","author":"M Messerer","year":"2011","unstructured":"M. Messerer et al. Evidence of improved surgical outcome following endoscopy for nonfunctioning pituitary adenoma removal. Neurosurg. Focus 30(4), E11 (2011)","journal-title":"Neurosurg. Focus"},{"issue":"1","key":"3400_CR24","doi-asserted-by":"publisher","first-page":"166","DOI":"10.1007\/s12020-021-02701-5","volume":"73","author":"O Alexopoulou","year":"2021","unstructured":"O. Alexopoulou et al. Outcome of pituitary hormone deficits after surgical treatment of nonfunctioning pituitary macroadenomas. Endocrine 73(1), 166\u2013176 (2021)","journal-title":"Endocrine"},{"issue":"12","key":"3400_CR25","doi-asserted-by":"publisher","first-page":"2514","DOI":"10.1016\/j.clineuro.2013.10.007","volume":"115","author":"M Messerer","year":"2013","unstructured":"M. Messerer et al. Non-functioning pituitary macro-incidentalomas benefit from early surgery before becoming symptomatic. Clin. Neurol. Neurosurg. 115(12), 2514\u20132520 (2013)","journal-title":"Clin. Neurol. Neurosurg."},{"issue":"10","key":"3400_CR26","doi-asserted-by":"publisher","first-page":"3696","DOI":"10.1210\/jcem.84.10.6019","volume":"84","author":"SM Webb","year":"1999","unstructured":"S.M. Webb et al. Recovery of hypopituitarism after neurosurgical treatment of pituitary adenomas. J. Clin. Endocrinol. Metab. 84(10), 3696\u20133700 (1999)","journal-title":"J. Clin. Endocrinol. Metab."},{"issue":"1","key":"3400_CR27","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s00701-003-0174-3","volume":"146","author":"P Nomikos","year":"2004","unstructured":"P. Nomikos et al. Impact of primary surgery on pituitary function in patients with non-functioning pituitary adenomas\u2014a study on 721 patients. Acta Neurochir. 146(1), 27\u201335 (2004)","journal-title":"Acta Neurochir."},{"issue":"4","key":"3400_CR28","doi-asserted-by":"publisher","first-page":"709","DOI":"10.1227\/01.NEU.0000325725.77132.90","volume":"63","author":"N Fatemi","year":"2008","unstructured":"N. Fatemi et al. Pituitary hormonal loss and recovery after transsphenoidal adenoma removal. Neurosurgery 63(4), 709\u2013718 (2008).","journal-title":"Neurosurgery"},{"issue":"3","key":"3400_CR29","doi-asserted-by":"publisher","first-page":"589","DOI":"10.3171\/2015.1.JNS141543","volume":"124","author":"A Jahangiri","year":"2016","unstructured":"A. Jahangiri et al. Improved versus worsened endocrine function after transsphenoidal surgery for nonfunctional pituitary adenomas: rate, time course, and radiological analysis. J. Neurosurg. 124(3), 589\u2013595 (2016)","journal-title":"J. Neurosurg."},{"issue":"4","key":"3400_CR30","doi-asserted-by":"publisher","first-page":"389","DOI":"10.1007\/s11102-020-01045-z","volume":"23","author":"JY Hwang","year":"2020","unstructured":"J.Y. Hwang et al. Axis-specific analysis and predictors of endocrine recovery and deficits for non-functioning pituitary adenomas undergoing endoscopic transsphenoidal surgery. Pituitary 23(4), 389\u2013399 (2020)","journal-title":"Pituitary"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03400-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-023-03400-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-023-03400-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,6,26]],"date-time":"2023-06-26T12:15:36Z","timestamp":1687781736000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-023-03400-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,5,24]]},"references-count":30,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2023,8]]}},"alternative-id":["3400"],"URL":"https:\/\/doi.org\/10.1007\/s12020-023-03400-z","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,5,24]]},"assertion":[{"value":"1 February 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"10 May 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"24 May 2023","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}